Vaxchora regulatory update

FDA approved a BLA from PaxVax for Vaxchora to prevent cholera caused by Vibrio cholerae serogroup O1 in adults ages 18-64 traveling to cholera-affected areas. PaxVax received a Priority Review vouche...